1. Home
  2. AYTU vs HIHO Comparison

AYTU vs HIHO Comparison

Compare AYTU & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • HIHO
  • Stock Information
  • Founded
  • AYTU N/A
  • HIHO 1990
  • Country
  • AYTU United States
  • HIHO Hong Kong
  • Employees
  • AYTU N/A
  • HIHO N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • HIHO Industrial Machinery/Components
  • Sector
  • AYTU Health Care
  • HIHO Industrials
  • Exchange
  • AYTU Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • AYTU 8.3M
  • HIHO 8.2M
  • IPO Year
  • AYTU N/A
  • HIHO 1996
  • Fundamental
  • Price
  • AYTU $1.15
  • HIHO $1.80
  • Analyst Decision
  • AYTU
  • HIHO
  • Analyst Count
  • AYTU 0
  • HIHO 0
  • Target Price
  • AYTU N/A
  • HIHO N/A
  • AVG Volume (30 Days)
  • AYTU 37.1K
  • HIHO 2.1K
  • Earning Date
  • AYTU 05-14-2025
  • HIHO 01-21-2025
  • Dividend Yield
  • AYTU N/A
  • HIHO 6.67%
  • EPS Growth
  • AYTU N/A
  • HIHO N/A
  • EPS
  • AYTU N/A
  • HIHO N/A
  • Revenue
  • AYTU $77,232,000.00
  • HIHO $7,345,000.00
  • Revenue This Year
  • AYTU N/A
  • HIHO N/A
  • Revenue Next Year
  • AYTU $8.14
  • HIHO N/A
  • P/E Ratio
  • AYTU N/A
  • HIHO N/A
  • Revenue Growth
  • AYTU N/A
  • HIHO 11.36
  • 52 Week Low
  • AYTU $1.15
  • HIHO $1.70
  • 52 Week High
  • AYTU $3.45
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 33.76
  • HIHO 41.05
  • Support Level
  • AYTU $1.20
  • HIHO $1.83
  • Resistance Level
  • AYTU $1.29
  • HIHO $1.88
  • Average True Range (ATR)
  • AYTU 0.06
  • HIHO 0.03
  • MACD
  • AYTU 0.00
  • HIHO -0.01
  • Stochastic Oscillator
  • AYTU 0.00
  • HIHO 0.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.

Share on Social Networks: